$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000088616316000208 Filed on August 04, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$19.52M	$18.42M
YoY Change	5.99%	73.62%
Cost Of Revenue	$720.0K	$2.600M
YoY Change	-72.31%	119.22%
Gross Profit	$18.80M	$15.82M
YoY Change	18.86%	67.88%
Gross Profit Margin	96.31%	85.88%
Selling, General & Admin	$6.860M	$7.230M
YoY Change	-5.12%	37.98%
% of Gross Profit	36.49%	45.71%
Research & Development	$4.914M	$3.416M
YoY Change	43.85%	27.04%
% of Gross Profit	26.14%	21.6%
Depreciation & Amortization	$100.0K	$635.0K
YoY Change	-84.25%	-5.08%
% of Gross Profit	0.53%	4.01%
Operating Expenses	$4.914M	$3.416M
YoY Change	43.85%	27.04%
Operating Profit	$3.969M	$4.365M
YoY Change	-9.07%	221.43%
Interest Expense	$3.051M	$2.969M
YoY Change	2.76%	1540.33%
% of Operating Profit	76.87%	68.02%
Other Income/Expense, Net	-$14.02M	$17.93M
YoY Change	-178.21%	-15422.22%
Pretax Income	-$10.05M	$22.29M
YoY Change	-145.09%	1696.29%
Income Tax	-$3.881M	$265.0K
% Of Pretax Income		1.19%
Net Earnings	-$6.170M	$23.56M
YoY Change	-126.18%	1380.15%
Net Earnings / Revenue	-31.61%	127.94%
Basic Earnings Per Share	-$0.30	$1.19
Diluted Earnings Per Share	-$0.30	$1.11
COMMON SHARES
Basic Shares Outstanding	20.83M shares	19.73M shares
Diluted Shares Outstanding	20.83M shares	21.28M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.0M	$181.6M
YoY Change	-41.08%	725.45%
Cash & Equivalents	$61.35M	$108.2M
Short-Term Investments	$45.60M	$73.40M
Other Short-Term Assets	$2.602M	$1.801M
YoY Change	44.48%	60.37%
Inventory	$3.835M	$802.0K
Prepaid Expenses	$2.122M	$1.206M
Receivables	$10.00M	$5.500M
Other Receivables	$3.700M	$7.000M
Total Short-Term Assets	$126.6M	$196.7M
YoY Change	-35.67%	588.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.181M	$405.0K
YoY Change	191.6%	-34.57%
Goodwill	$72.36M	$12.24M
YoY Change	491.27%	0.0%
Intangibles	$210.1M	$49.54M
YoY Change	324.23%	-4.58%
Long-Term Investments	$18.73M	$34.00M
YoY Change	-44.9%
Other Assets	$603.0K	$301.0K
YoY Change	100.33%	18.97%
Total Long-Term Assets	$490.2M	$108.0M
YoY Change	353.77%	51.61%
TOTAL ASSETS
Total Short-Term Assets	$126.6M	$196.7M
Total Long-Term Assets	$490.2M	$108.0M
Total Assets	$616.8M	$304.8M
YoY Change	102.39%	205.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.336M	$2.708M
YoY Change	-13.74%	-46.47%
Accrued Expenses	$4.951M	$5.629M
YoY Change	-12.04%	73.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$207.6M	$1.600M
YoY Change	12875.0%	-70.37%
Total Short-Term Liabilities	$220.3M	$17.95M
YoY Change	1127.63%	-3.61%
LONG-TERM LIABILITIES
Long-Term Debt	$34.70M	$200.8M
YoY Change	-82.72%	12450.0%
Other Long-Term Liabilities	$398.0K	$734.0K
YoY Change	-45.78%	0.82%
Total Long-Term Liabilities	$398.0K	$734.0K
YoY Change	-45.78%	0.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$220.3M	$17.95M
Total Long-Term Liabilities	$398.0K	$734.0K
Total Liabilities	$224.9M	$235.7M
YoY Change	-4.59%	541.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$401.2M	-$635.0M
YoY Change	-36.82%	-4.89%
Common Stock	$21.00K	$20.00K
YoY Change	5.0%	-4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$391.9M	$69.05M
YoY Change
Total Liabilities & Shareholders Equity	$616.8M	$304.8M
YoY Change	102.39%	205.23%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$6.170M	$23.56M
YoY Change	-126.18%	1380.15%
Depreciation, Depletion And Amortization	$100.0K	$635.0K
YoY Change	-84.25%	-5.08%
Cash From Operating Activities	$10.40M	$10.00M
YoY Change	4.0%	150.0%
INVESTING ACTIVITIES
Capital Expenditures	-$18.50M	-$4.100M
YoY Change	351.22%
Acquisitions
YoY Change
Other Investing Activities	$36.70M	-$68.20M
YoY Change	-153.81%	-11466.67%
Cash From Investing Activities	$18.30M	-$72.20M
YoY Change	-125.35%	-12133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.500M	4.600M
YoY Change	-67.39%	-248.39%
NET CHANGE
Cash From Operating Activities	10.40M	10.00M
Cash From Investing Activities	18.30M	-72.20M
Cash From Financing Activities	1.500M	4.600M
Net Change In Cash	30.20M	-57.60M
YoY Change	-152.43%	-3940.0%
FREE CASH FLOW
Cash From Operating Activities	$10.40M	$10.00M
Capital Expenditures	-$18.50M	-$4.100M
Free Cash Flow	$28.90M	$14.10M
YoY Change	104.96%	252.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20854368	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INC
CY2015Q2	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	1131000	USD
	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	1717000	USD
CY2016Q2	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	5881000	USD
	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	15798000	USD
CY2015Q4	lgnd	Commercial License Rights CommercialLicenseRights	8554000	USD
	lgnd	Income Tax Provision Discontinued Operation Dilutedper Share IncomeTaxProvisionDiscontinuedOperationDilutedperShare	0.02
CY2015Q2	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.01
CY2016Q2	lgnd	Commercial License Rights CommercialLicenseRights	26141000	USD
CY2015Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	10414000	USD
CY2016Q2	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	5337000	USD
CY2015Q4	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	268000	USD
CY2016Q2	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	42000	USD
	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	0.011
	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	0.406
	lgnd	Equity Receivedin Repaymentof Note Receivable EquityReceivedinRepaymentofNoteReceivable	0	USD
	lgnd	Equity Receivedin Repaymentof Note Receivable EquityReceivedinRepaymentofNoteReceivable	1200000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2014Q3	lgnd	Exercise Priceof Convertible Bond Hedge ExercisePriceofConvertibleBondHedge	75.05
	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities	473000	USD
	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.01
CY2016Q2	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.19
	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.01
CY2016Q2	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivable IncreaseDecreaseinFairValueofConvertibleDebtReceivable	200000	USD
	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivable IncreaseDecreaseinFairValueofConvertibleDebtReceivable	200000	USD
	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivableand Warrant IncreaseDecreaseinFairValueofConvertibleDebtReceivableandWarrant	0	USD
	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivableand Warrant IncreaseDecreaseinFairValueofConvertibleDebtReceivableandWarrant	310000	USD
	lgnd	Lease Expiration Year Maximum LeaseExpirationYearMaximum	2023
	lgnd	Lease Expiration Year Minimum LeaseExpirationYearMinimum	2016
CY2015Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	3033000	USD
CY2016Q2	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	4138000	USD
	lgnd	Maturity Period Of Highly Liquid Securities Maximum MaturityPeriodOfHighlyLiquidSecuritiesMaximum	P3M
CY2015Q2	lgnd	Net Income Attributableto Parent Excluding Discontinued Operations NetIncomeAttributabletoParentExcludingDiscontinuedOperations	23564000	USD
	lgnd	Net Income Attributableto Parent Excluding Discontinued Operations NetIncomeAttributabletoParentExcludingDiscontinuedOperations	24318000	USD
CY2016Q2	lgnd	Net Income Attributableto Parent Excluding Discontinued Operations NetIncomeAttributabletoParentExcludingDiscontinuedOperations	-5763000	USD
	lgnd	Net Income Attributableto Parent Excluding Discontinued Operations NetIncomeAttributabletoParentExcludingDiscontinuedOperations	114000	USD
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-7277000	USD
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-1638000	USD
	lgnd	Non Restricted Equity And Debt Securities With Maturity Period NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod	P3M
CY2015Q2	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	200000	USD
	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	400000	USD
CY2016Q2	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	300000	USD
	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	500000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Due After Four Years OperatingLeasesFutureMinimumPaymentsDueAfterFourYears	270000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due After Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueAfterFourYears	270000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due Next Twelve Months OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueNextTwelveMonths	517000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Oneand Two Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinOneandTwoYears	364000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Threeand Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinThreeandFourYears	278000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Duein Oneand Two Years OperatingLeasesFutureMinimumPaymentsDueinOneandTwoYears	1764000	USD
CY2016Q2	lgnd	Operating Leases Future Minimum Payments Duein Threeand Four Years OperatingLeasesFutureMinimumPaymentsDueinThreeandFourYears	278000	USD
CY2016Q2	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum	0.035
CY2016Q2	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum	0.03
CY2015Q4	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	29000	USD
CY2016Q2	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	30000	USD
	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	3663000	USD
	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	5635000	USD
	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	4030000	USD
	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	17691000	USD
	lgnd	Sales Returns Restocking Fee Percent SalesReturnsRestockingFeePercent	0.2
CY2015Q2	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.085
	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.085
CY2016Q2	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.050
	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.050
CY2015Q4	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	934000	USD
CY2016Q2	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	239000	USD
	lgnd	Stock Receivedas Repaymentof Note Receivable Fair Value StockReceivedasRepaymentofNoteReceivableFairValue	1060000	USD
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	731000	USD
CY2016Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	480000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4083000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2336000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	34000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-331000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5397000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4951000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	726000	USD
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	828000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	823000	USD
CY2016Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1037000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2781000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1503000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4903000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3745000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	701478000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	789315000	USD
CY2014Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	11600000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	3760000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	6675000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	4240000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8359000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5058000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5378000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5200000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3500000	shares
CY2015Q4	us-gaap	Assets Assets	530542000	USD
CY2016Q2	us-gaap	Assets Assets	616799000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	214712000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	126563000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	102791000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	45603000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4944000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3334000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	44000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	97891000	USD
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	42270000	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-7274000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-7277000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-332000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-1638000	USD
CY2015Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	218000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	441000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	374000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	618000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160203000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108238000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97428000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61350000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-51965000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36078000	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	247000	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	125.08
CY2014Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3264643	shares
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25494000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19949012	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20853127	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19949012	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20853127	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	21000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30629000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5588000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-314000	USD
CY2015Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2016Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	207363000	USD
CY2015Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	201985000	USD
CY2016Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3673000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	720000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1675000	USD
CY2015Q2	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	594000	USD
	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	1188000	USD
CY2016Q2	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2681000	USD
	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	5206000	USD
CY2015Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	28190000	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	28190000	USD
CY2016Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	326000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	216564000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	161076000	USD
	us-gaap	Depreciation Depreciation	100000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1296000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5388000	USD
CY2015Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2016Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1139000	USD
CY2015Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
CY2016Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	731000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	400000	USD
CY2015Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
CY2016Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	408000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.24
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1711000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1463000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	29728000	USD
CY2016Q2	us-gaap	Equity Method Investments EquityMethodInvestments	18733000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	215000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4782000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3207000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	2992000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9490000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6971000	USD
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-133000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7225000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13219000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6863000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13691000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	12238000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	72360000	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22292000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22217000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9644000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-73000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	22027000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	21938000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5763000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	114000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.19
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.24
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.28
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.11
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.28
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Taxes Paid IncomeTaxesPaid	13000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	36000	USD
	us-gaap	Interest Paid InterestPaid	919000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3881000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-187000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-870000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-870000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11138000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12743000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	279000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3107000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3323000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7102000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3791000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-268000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-187000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-110000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	113000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	16000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	533000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2202000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	598000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	42000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	462000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	629000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-661000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	463232	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	231617	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	977339	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1044926	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1001147	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	785921	shares
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48347000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	210142000	USD
CY2015Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	60585000	USD
CY2016Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	282502000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	2969000	USD
	us-gaap	Interest Expense InterestExpense	5945000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	3051000	USD
	us-gaap	Interest Expense InterestExpense	6055000	USD
	us-gaap	Interest Paid InterestPaid	903000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	915000	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	852000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	530542000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	616799000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	224883000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1633000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	3835000	USD
CY2015Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2016Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	226151000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20836000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	220347000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5430000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1980000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75020000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61543000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17625000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23485000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	23564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	24318000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-5763000	USD
	us-gaap	Net Income Loss NetIncomeLoss	845000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1537000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2380000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17927000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14502000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14020000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19544000	USD
CY2015Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4782000	USD
CY2016Q2	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	3207000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14053000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	25305000	USD
CY2016Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	15145000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	29698000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4365000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	7715000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4376000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	19471000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3584000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1272000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	1429000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2482000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5430000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	900000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1900000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1200000	USD
CY2016Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	8900000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1222000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	771000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1908000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2602000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	603000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3230000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7844000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	539000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-559000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1300000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1533000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	364000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	600000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8000	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	121000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	297000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	398000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	850000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	404000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	501000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	892000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	502000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	92504000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	9000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	700000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1021000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	60432000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	49892000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1177000	USD
CY2016Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2122000	USD
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	300000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	83523000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2378000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	22077000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	22027000	USD
	us-gaap	Profit Loss ProfitLoss	21938000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-5763000	USD
	us-gaap	Profit Loss ProfitLoss	845000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3153000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2684000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	372000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1181000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	502000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	602000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	6170000	USD
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9966000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3416000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6784000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4507000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8508000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-402010000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-401165000	USD
CY2015Q2	us-gaap	Revenues Revenues	18418000	USD
	us-gaap	Revenues Revenues	33020000	USD
CY2016Q2	us-gaap	Revenues Revenues	19521000	USD
	us-gaap	Revenues Revenues	49169000	USD
CY2015Q2	us-gaap	Royalty Revenue RoyaltyRevenue	6606000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	16893000	USD
CY2016Q2	us-gaap	Royalty Revenue RoyaltyRevenue	9754000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	24144000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10681000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	14410000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3886000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9227000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6675000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8359000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	24282	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	254989	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1683341	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	77243	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1836805	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.23
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.83
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	30.73
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	61.99
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	90.51
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M22D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7M6D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y8M5D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7M6D
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	102791000	USD
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	45603000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	-77615000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	304391000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	391916000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7844000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1198000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6400000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21276000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21276404	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20953000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20953134	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20831809	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20832000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22614732	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22615000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19725410	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19668183	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20831809	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20765053	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19725000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19668000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20832000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20765000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	42836	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	52187	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	86419	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications<br clear="none"/> <br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to the previously issued balance sheet and statement of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> for comparability purposes. These reclassifications had no effect on the reported net income, stockholders' equity, and operating cash flows as previously reported.</font></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000886163-16-000208-index-headers.html	Edgar Link	pending
0000886163-16-000208-index.html	Edgar Link	pending
0000886163-16-000208.txt	Edgar Link	pending
0000886163-16-000208-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lgnd-20160630.xml	Edgar Link	completed
lgnd-20160630.xsd	Edgar Link	pending
lgnd-20160630_cal.xml	Edgar Link	unprocessable
lgnd-20160630_def.xml	Edgar Link	unprocessable
lgnd-20160630_lab.xml	Edgar Link	unprocessable
lgnd-20160630_pre.xml	Edgar Link	unprocessable
lgnd-6301610q.htm	Edgar Link	pending
lgnd_63016exhibit311.htm	Edgar Link	pending
lgnd_63016exhibit312.htm	Edgar Link	pending
lgnd_63016exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2016 Q2 Form 10-Q Financial Statement

#000088616316000208 Filed on August 04, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2016 Q2 Form 10-Q Financial Statement

#000088616316000208 Filed on August 04, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd